Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies

NCT05583175 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myeloid, Acute
MDS
Hematopoietic Stem Cell Transplantation
Myeloid Malignancy

Interventions

DRUG: Venetoclax plus RIC

Sponsor

Xianmin Song, MD